abstract |
The present invention relates to a triaminopyrimidine compound 1, or pharmaceutically acceptable salts thereof, or hydrates, solvates, polymorphs, or optically active forms thereof, in solid state forms. The present invention also relates to a process for preparing a triaminopyrimidine compound and its intermediates. The present invention further relates to a pharmaceutical composition comprising the pure triaminopyrimidine compound, useful in the prevention or treatment of malaria. |